What are the implications of the revised Schedule M of Drugs and Cosmetics Act for pharmaceutical units
Understand the impact of the 12-month extension given to implement the revised Schedule M of Drugs and Cosmetics Act on pharma units.
© amITsoft Core Private Limited 2023
| ID | 39653 |
|---|---|
| Votes | 0 |
| Added | 05 Jan 2025 |
| Updated | 11 Mar 2025 |
| Subject | Health |
© amITsoft Core Private Limited 2023